Alaris buys rights to infusion pump technology:
This article was originally published in Clinica
Alaris Medical is to license Caesarea Medical Electronics' pole-mounted volumetric infusion pump technology in an exclusive agreement. Alaris will build intravenous infusion pumps using the technology at its factory in Basingstoke, in the UK. Alaris claims a leading position in infusion systems internationally, and the company will direct the new product at developing markets, initially Latin America and the Far East. Alaris, of San Diego in the US, will then adapt the product for the international infusion, general care hospital and homecare markets. It estimates the combined market potential of these businesses at around $100 million.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.